← SynDRA
BLARCAMESINE
SynDRA canonical compound SYN0039433 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CHRM2 | CHRM3 | SIGMAR1 |
|---|
| Mechanism of action | sigma receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Blarcamesina
- Anavex 2-73
- Anavex
- THD-DP-FM
- anavex2-73
- Blarcamesine [USAN]
- blarcamesina
- AE 37
- UNII-9T210MMZ3F
- 9T210MMZ3F
- Tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanemethanamine
- BLARCAMESINE [INN]
- Blarcamesine (USAN)
- Tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine
- 3-Furanmethanamine, tetrahydro-N,N-dimethyl-2,2-diphenyl-
- [(2,2-diphenyloxolan-3-yl)methyl]dimethylamine
- RAC-1-((3R)-2,2-DIPHENYLOXOLAN-3-YL)-N,N-DIMETHYLMETHANAMINE
- ((2,2-diphenyloxolan-3-yl)methyl)dimethylamine
- blarcamesinum
- RefChem:120604
- ANAVEX2-73 free base
- ANAVEX 2-73 FREE BASE
- AVex-73
- 1-(2,2-diphenyloxolan-3-yl)-N,N-dimethylmethanamine
- AE37
- 1-(2,2-Diphenyltetrahydrofuran-3-yl)-N,N-dimethylmethanamine
- Blarcamesine [WHO-DD]
- Blarcamesine (USAN/INN)
- AN2/AVex-73
- SCHEMBL181634
- orb1299513
- GTPL11586
- EX-A3143
- VHA61583
- BDBM50559171
- AKOS040759257
- SB17187
- Anavex-2-73 free base (Blarcamesine)?
- NCGC00387227-01
Look up BLARCAMESINE in the interactive SynDRA portal →